Home › Non-Small Cell Lung Cancer › Iowa › Ames
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Ames, IA
6 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Ames (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Nagre-recruitPhase 3
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Nagre-recruitPhase 3
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 2
- Accellacare of McFarland, Ames
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Ames
- Kanser sa Prostate7 pag-aaral
- Kanser sa Baga7 pag-aaral
- Kanser sa Bato (Renal Cell Carcinoma)5 pag-aaral
- Kanser sa Suso4 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg4 pag-aaral
- Kanser sa Pantog4 pag-aaral
- Chronic Lymphocytic Leukemia3 pag-aaral
- Kanser ng Hipoparynk3 pag-aaral
- Kanser sa Larynx3 pag-aaral
- Kanser sa Bibig3 pag-aaral
- Melanoma3 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.